Back
Theravance Biopharma Vs. Corcept Therapeutics Industry Stock Comparison
Sell
28
TBPH
Theravance Biopharma
Last Price:
9.26
Seasonality Move:
-9.27%
Buy
80
CORT
Corcept Therapeutics
Last Price:
28.09
Seasonality Move:
6.24%
Sell
28
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.29. The Score for TBPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- TBPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $28.09. The Score for CORT is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $28.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
TBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 48.81 | Sell |
| Chaikin Money Flow: | -238819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.05 - 9.67) | Sell |
| Bollinger Bands (100): | (8.64 - 10.1) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 70.67 | Buy |
| Chaikin Money Flow: | 329341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.59 - 26.55) | Buy |
| Bollinger Bands (100): | (22.1 - 26.58) | Buy |
TBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.51 | Sell |
| 20-day SMA: | 9.32 | Sell |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 9.59 | Sell |
| 8-day EMA: | 9.48 | Sell |
| 20-day EMA: | 9.39 | Sell |
| 50-day EMA: | 9.3 | Sell |
| 200-day EMA: | 9.61 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.21 | Buy |
| 20-day SMA: | 24.96 | Buy |
| 50-day SMA: | 24.55 | Buy |
| 200-day SMA: | 26.69 | Buy |
| 8-day EMA: | 27.08 | Buy |
| 20-day EMA: | 25.75 | Buy |
| 50-day EMA: | 24.84 | Buy |
| 200-day EMA: | 25.19 | Buy |
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.05 per share.
Theravance Biopharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||